Form
4
insider filings, from the source
Buys
Significant
Penny
Sales
Options
Clusters
Screener
Ratios
Learn
/
Insider · CIK 0001579179
Todd C Brady
Files at:
ALDX
,
SBPH
,
EVOK
,
OTLK
.
On EDGAR ↗
Period
1M
3M
6M
1Y
2Y
All data
shares as filed — not split-adjusted
Open-market buys & sales
buys $518k · 2
sales $0 · 0
net $518k
$10k
$10k
$100k
$100k
$1M
$1M
buys
sales
Feb 2017
Sep 2018
Mar 2020
Oct 2021
Apr 2023
Nov 2024
Jun 2026
Reported trades — common stock
Trade
Reported (ET)
Company
Shares
Avg price
Total
Owned after
Δ stake
Flags
Jun 3, 2026
P
Form 4 →
Jun 5, 4:19 pm EDT
Aldeyra Therapeutics, Inc.
ALDX
250,000
$1.67
$418,450
1,721,298
+17.0%
Mar 5, 2019
A
Form 4 →
Mar 7, 5:20 pm EST
Aldeyra Therapeutics, Inc.
ALDX
250,000
—
—
556,054
—
plan?
Mar 6, 2018
A
Form 4 →
Mar 8, 4:40 pm EST
Aldeyra Therapeutics, Inc.
ALDX
101,269
—
—
302,483
—
plan?
Jan 2, 2018
A
Form 4 →
Jan 3, 4:12 pm EST
Spring Bank Pharmaceuticals, Inc.
SBPH
852
—
—
13,094
—
plan?
Oct 2, 2017
A
Form 4 →
Oct 3, 4:04 pm EDT
Spring Bank Pharmaceuticals, Inc.
SBPH
633
—
—
12,242
—
plan?
Jul 3, 2017
A
Form 4 →
Jul 5, 4:08 pm EDT
Spring Bank Pharmaceuticals, Inc.
SBPH
645
—
—
11,609
—
plan?
Mar 3, 2017
A
Form 4 →
Mar 7, 5:45 pm EST
Aldeyra Therapeutics, Inc.
ALDX
136,806
—
—
201,214
—
plan?
Feb 17, 2017
P
Form 4 →
Feb 21, 4:32 pm EST
Aldeyra Therapeutics, Inc.
ALDX
22,223
$4.50
$100,004
64,408
+52.7%
plan?
Nov 23, 2016
A
Form 4 →
Nov 23, 4:00 pm EST
Spring Bank Pharmaceuticals, Inc.
SBPH
10,964
$9.12
$99,992
10,964
—
plan?
Nov 9, 2016
C
M
Form 4 →
Nov 14, 6:15 pm EST
Oncobiologics, Inc.
ONS
57,970
—
—
153,288
—
plan?
late
May 18, 2016
C
Form 4 →
May 18, 1:23 pm EDT
Oncobiologics, Inc.
ONS
66,333
—
—
124,303
—
plan?
May 3, 2016
A
Form 4 →
May 5, 4:06 pm EDT
Aldeyra Therapeutics, Inc.
ALDX
27,096
—
—
42,185
—
plan?
Reported trades — derivatives (options, RSUs, warrants)
Trade
Reported (ET)
Company
Shares
Avg price
Total
Owned after
Δ stake
Flags
Mar 5, 2019
A
Form 4 →
Mar 7, 5:20 pm EST
Aldeyra Therapeutics, Inc.
ALDX
295,329
—
—
45,329
—
Jun 18, 2018
A
Form 4 →
Jun 19, 4:28 pm EDT
Spring Bank Pharmaceuticals, Inc.
SBPH
5,500
—
—
5,500
—
Apr 26, 2018
A
Form 4 →
Apr 27, 4:22 pm EDT
Evoke Pharma Inc
EVOK
34,000
—
—
34,000
—
Mar 6, 2018
A
Form 4 →
Mar 8, 4:40 pm EST
Aldeyra Therapeutics, Inc.
ALDX
217,293
—
—
217,293
—
Oct 26, 2017
A
Form 4 →
Oct 30, 6:03 pm EDT
Oncobiologics, Inc.
ONS
15,000
—
—
15,000
—
Jun 15, 2017
A
Form 4 →
Jun 16, 4:49 pm EDT
Spring Bank Pharmaceuticals, Inc.
SBPH
5,500
—
—
5,500
—
May 3, 2017
A
Form 4 →
May 5, 5:58 pm EDT
Evoke Pharma Inc
EVOK
34,000
—
—
34,000
—
Mar 3, 2017
A
Form 4 →
Mar 7, 5:45 pm EST
Aldeyra Therapeutics, Inc.
ALDX
250,000
—
—
250,000
—
Nov 23, 2016
A
Form 4 →
Nov 23, 4:00 pm EST
Spring Bank Pharmaceuticals, Inc.
SBPH
10,964
—
—
10,964
—
Jul 28, 2016
A
Form 4 →
Jul 29, 2:39 pm EDT
Spring Bank Pharmaceuticals, Inc.
SBPH
11,000
—
—
11,000
—
May 18, 2016
C
Form 4 →
May 18, 1:23 pm EDT
Oncobiologics, Inc.
ONS
398
—
—
0
—
Apr 27, 2016
A
Form 4 →
Apr 29, 6:18 pm EDT
Evoke Pharma Inc
EVOK
19,000
—
—
19,000
—
Mar 16, 2016
A
Form 4/A →
May 5, 4:05 pm EDT
Aldeyra Therapeutics, Inc.
ALDX
250,000
—
—
250,000
—
Mar 16, 2016
A
Form 4 →
Mar 18, 5:01 pm EDT
Aldeyra Therapeutics, Inc.
ALDX
300,000
—
—
300,000
—
amended
Jun 3, 2015
A
Form 4 →
Jun 5, 5:02 pm EDT
Aldeyra Therapeutics, Inc.
ALDX
90,000
—
—
90,000
—
Apr 22, 2015
A
Form 4 →
Apr 24, 2:06 pm EDT
Evoke Pharma Inc
EVOK
9,000
—
—
9,000
—